1. Immunology/Inflammation Apoptosis
  2. COX Apoptosis
  3. Diclofenac Sodium

Diclofenac Sodium  (Synonyms: GP 45840)

Cat. No.: HY-15037 Purity: 99.81%
Handling Instructions Technical Support

Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade.

For research use only. We do not sell to patients.

CAS No. : 15307-79-6

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
500 mg In-stock
5 g In-stock
10 g   Get quote  
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 24 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Diclofenac Sodium purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2022 Oct 11;23(20):12066.

    KATOIII and KATO/DDP were treated with different concentration of Diclofenac (DCF) (0–1000 µM) for 48 h, and cell viability was assessed.

    Diclofenac Sodium purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2022 Oct 11;23(20):12066.

    The KATO/DDP cells were treated with Cisplatin alone or cisplatin in combination with Diclofenac (DCF) at 10 or 20 µM for 24 h, at 37 °C. The apoptosis cells were detected by using annexin V and PI staining and analyzed by flow cytometer.

    Diclofenac Sodium purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2022 Oct 11;23(20):12066.

    The combination effect of Diclofenac (DCF) (0, 5, 10, 20 μM) and Cisplatin on the expression of cleaved PARP in KATO/DDP cells was examined by Western blot analysis.

    Diclofenac Sodium purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2022 Oct 11;23(20):12066.

    The formation of autophagic vacuoles in KATO/DDP cells increased from 27% to 39% and 45% in cotreatments involving cisplatin and Diclofenac (DCF) at 10 and 20 μM, respectively, when compared with treatment of cisplatin alone.

    View All COX Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively[2]. Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade[3].

    IC50 & Target[1][2]

    Human COX-2

    1.3 nM (IC50, in CHO cells)

    Human COX-1

    4 nM (IC50, in CHO cells)

    Ovine COX-2

    0.84 μM (IC50)

    Ovine COX-1

    5.1 μM (IC50)

    Cellular Effect
    Cell Line Type Value Description References
    Erythrocyte EC50
    11.7 μg/mL
    Compound: Diclofenac sodium
    Anti-inflammatory activity in human red blood cells assessed as stabilization of cell membrane
    Anti-inflammatory activity in human red blood cells assessed as stabilization of cell membrane
    [PMID: 32485533]
    HT-29 IC50
    137.1 μM
    Compound: Diclofenac sodium
    Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 24 hrs by MTS assay
    Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 24 hrs by MTS assay
    [PMID: 32485532]
    RAW264.7 IC50
    10.27 μM
    Compound: Diclofenac sodium
    Inhibition of LPS-induced TNFalpha production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
    Inhibition of LPS-induced TNFalpha production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
    [PMID: 33892270]
    RAW264.7 IC50
    12.19 μM
    Compound: Diclofenac sodium
    Inhibition of LPS-induced 15(S)-HETE production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
    Inhibition of LPS-induced 15(S)-HETE production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
    [PMID: 33892270]
    RAW264.7 IC50
    12.91 μM
    Compound: Diclofenac sodium
    Inhibition of LPS-induced IL-6 production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
    Inhibition of LPS-induced IL-6 production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
    [PMID: 33892270]
    RAW264.7 IC50
    25.51 μM
    Compound: Diclofenac sodium
    Antioxidant activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced intracellular ROS production preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by DCFH-DA staining based fluorescence analysis
    Antioxidant activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced intracellular ROS production preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by DCFH-DA staining based fluorescence analysis
    [PMID: 33892270]
    RAW264.7 IC50
    331 μM
    Compound: Diclofenac sodium
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs by Griess reagent based analysis
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs by Griess reagent based analysis
    [PMID: 38805684]
    RAW264.7 IC50
    36.28 μM
    Compound: Diclofenac sodium
    Inhibition of LPS-induced NO production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by DAF-FM based fluorescence analysis
    Inhibition of LPS-induced NO production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by DAF-FM based fluorescence analysis
    [PMID: 33892270]
    THP-1 IC50
    200.9 μM
    Compound: Diclofenac sodium
    Cytotoxicity against PMA/LPS-challenged human THP1 cells assessed as reduction in cell viability incubated for 24 hrs by MTS assay
    Cytotoxicity against PMA/LPS-challenged human THP1 cells assessed as reduction in cell viability incubated for 24 hrs by MTS assay
    [PMID: 32485532]
    In Vitro

    Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC50 of 7±3 nM[1].
    Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner[3].
    Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[3]

    Cell Line: Neural stem cells (NSCs)
    Concentration: 1, 3, 10, 30, 60 μM
    Incubation Time: 1 day
    Result: Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM.

    Western Blot Analysis[3]

    Cell Line: Neural stem cells (NSCs)
    Concentration: 10, 30 or 60 μM
    Incubation Time: 6 hours
    Result: The activation of caspase-3 was increased in a concentration-dependent manner.
    In Vivo

    Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal 51Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days[1].
    Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Male Sprague-Dawley rats (150±200 g)[1]
    Dosage: 3 mg/kg
    Administration: Oral administration, b.i.d., for 5 days
    Result: Resulted in a significant increase in faecal 51Cr excretion.
    Animal Model: Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema model[2]
    Dosage: 10 mg/kg
    Administration: Administered via oral route just prior to induction of inflammation
    Result: Showed in vivo anti-inflammatory activity (% edema inhibition=29.2, 1 h; 22.2, 3 h; 20, 6 h).
    Molecular Weight

    318.13

    Formula

    C14H10Cl2NNaO2

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C(O[Na])CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    4°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    Solvent & Solubility
    In Vitro: 

    DMSO : 125 mg/mL (392.92 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : 10 mg/mL (31.43 mM; ultrasonic and warming and heat to 60°C)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.1434 mL 15.7168 mL 31.4337 mL
    5 mM 0.6287 mL 3.1434 mL 6.2867 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  PBS

      Solubility: 4.55 mg/mL (14.30 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation

    Purity: 99.81%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O / DMSO 1 mM 3.1434 mL 15.7168 mL 31.4337 mL 78.5842 mL
    5 mM 0.6287 mL 3.1434 mL 6.2867 mL 15.7168 mL
    10 mM 0.3143 mL 1.5717 mL 3.1434 mL 7.8584 mL
    15 mM 0.2096 mL 1.0478 mL 2.0956 mL 5.2389 mL
    20 mM 0.1572 mL 0.7858 mL 1.5717 mL 3.9292 mL
    25 mM 0.1257 mL 0.6287 mL 1.2573 mL 3.1434 mL
    30 mM 0.1048 mL 0.5239 mL 1.0478 mL 2.6195 mL
    DMSO 40 mM 0.0786 mL 0.3929 mL 0.7858 mL 1.9646 mL
    50 mM 0.0629 mL 0.3143 mL 0.6287 mL 1.5717 mL
    60 mM 0.0524 mL 0.2619 mL 0.5239 mL 1.3097 mL
    80 mM 0.0393 mL 0.1965 mL 0.3929 mL 0.9823 mL
    100 mM 0.0314 mL 0.1572 mL 0.3143 mL 0.7858 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Diclofenac Sodium
    Cat. No.:
    HY-15037
    Quantity:
    MCE Japan Authorized Agent: